Literature DB >> 17255537

A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome.

Karsten Hartvigsen1, Christoph J Binder, Lotte F Hansen, Apaïs Rafia, Joseph Juliano, Sohvi Hörkkö, Daniel Steinberg, Wulf Palinski, Joseph L Witztum, Andrew C Li.   

Abstract

OBJECTIVE: Western-type high-fat/high-cholesterol diets used to induce atherogenesis in low-density lipoprotein (LDL) receptor-deficient mice also lead to obesity with concomitant metabolic complications, eg, hypertriglyceridemia, hyperinsulinemia, and insulin resistance. Our aim was to design a diet inducing atherosclerosis through moderate hypercholesterolemia without associated parameters of the metabolic syndrome. METHODS AND
RESULTS: Male LDL receptor-deficient mice were fed regular chow (RC; 0.01% cholesterol/4.4% fat), cholesterol-enriched regular chow (HC; 1% cholesterol/4.4% fat), or Western diet (WD 0.06% cholesterol/21% milk fat) for 28 weeks. HC-feeding led to elevated plasma (approximately 20.7 mmol/L [800 mg/dL]) and LDL cholesterol and accelerated atherosclerosis. Plasma triglycerides were unaffected. Compared with RC-fed controls, HC-fed mice had normal body weight gain and normal fasting levels of glucose, free fatty acids, and insulin. In contrast, WD-fed mice were extremely hypercholesterolemic (>41.4 mmol/L), obese, hypertriglyceridemic, hyperinsulinemic, insulin resistant, and showed adverse health such as skin/fur abnormalities and hepatic steatosis. Although atherosclerotic surface areas in the entire aorta were similar in HC-fed and WD-fed mice, lesions in aortic origin cross sections were significantly larger in WD-fed mice. However, morphology was similar in lesions of equal size.
CONCLUSIONS: The HC diet induced moderate hypercholesterolemia and extensive atherosclerosis and should be useful to study specific aspects of atherogenesis in the absence of confounding effects of the metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255537     DOI: 10.1161/01.ATV.0000258790.35810.02

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  39 in total

1.  Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish.

Authors:  Konstantin Stoletov; Longhou Fang; Soo-Ho Choi; Karsten Hartvigsen; Lotte F Hansen; Chris Hall; Jennifer Pattison; Joseph Juliano; Elizabeth R Miller; Felicidad Almazan; Phil Crosier; Joseph L Witztum; Richard L Klemke; Yury I Miller
Journal:  Circ Res       Date:  2009-03-05       Impact factor: 17.367

Review 2.  Animal models of atherosclerosis.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-01       Impact factor: 8.311

3.  Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression.

Authors:  Sotirios Tsimikas; Atsushi Miyanohara; Karsten Hartvigsen; Esther Merki; Peter X Shaw; Meng-Yun Chou; Jennifer Pattison; Michael Torzewski; Janina Sollors; Theodore Friedmann; N Chin Lai; H Kirk Hammond; Godfrey S Getz; Catherine A Reardon; Andrew C Li; Carole L Banka; Joseph L Witztum
Journal:  J Am Coll Cardiol       Date:  2011-10-11       Impact factor: 24.094

4.  Atheroprotective immunization with malondialdehyde-modified LDL is hapten specific and dependent on advanced MDA adducts: implications for development of an atheroprotective vaccine.

Authors:  Ayelet Gonen; Lotte F Hansen; William W Turner; Erica N Montano; Xuchu Que; Apaїs Rafia; Meng-Yun Chou; Philipp Wiesner; Dimitrios Tsiantoulas; Maripat Corr; Michael S VanNieuwenhze; Sotirios Tsimikas; Christoph J Binder; Joseph L Witztum; Karsten Hartvigsen
Journal:  J Lipid Res       Date:  2014-08-20       Impact factor: 5.922

5.  Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice.

Authors:  Adam E Mullick; Wuxia Fu; Mark J Graham; Richard G Lee; Donna Witchell; Thomas A Bell; Charles P Whipple; Rosanne M Crooke
Journal:  J Lipid Res       Date:  2011-02-22       Impact factor: 5.922

6.  Quantitative analysis and characterization of atherosclerotic lesions in the murine aortic sinus.

Authors:  Daniel E Venegas-Pino; Nicole Banko; Mohammed I Khan; Yuanyuan Shi; Geoff H Werstuck
Journal:  J Vis Exp       Date:  2013-12-07       Impact factor: 1.355

7.  AIBP protects against metabolic abnormalities and atherosclerosis.

Authors:  Dina A Schneider; Soo-Ho Choi; Colin Agatisa-Boyle; Laurence Zhu; Jungsu Kim; Jennifer Pattison; Dorothy D Sears; Philip L S M Gordts; Longhou Fang; Yury I Miller
Journal:  J Lipid Res       Date:  2018-03-20       Impact factor: 5.922

8.  Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice.

Authors:  K R Coenen; M L Gruen; R S Lee-Young; M J Puglisi; D H Wasserman; A H Hasty
Journal:  Diabetologia       Date:  2008-12-04       Impact factor: 10.122

9.  Hypertension and decreased aortic compliance due to reduced elastin amounts do not increase atherosclerotic plaque accumulation in Ldlr-/- mice.

Authors:  Justine A Maedeker; Kellie V Stoka; Siddharth A Bhayani; William S Gardner; Lisa Bennett; Jesse D Procknow; Marius C Staiculescu; Tezin A Walji; Clarissa S Craft; Jessica E Wagenseil
Journal:  Atherosclerosis       Date:  2016-03-21       Impact factor: 5.162

10.  Novel cerebrovascular pathology in mice fed a high cholesterol diet.

Authors:  Sonia Franciosi; Miguel A Gama Sosa; Daniel F English; Elizabeth Oler; Twethida Oung; William Gm Janssen; Rita De Gasperi; James Schmeidler; Dara L Dickstein; Christoph Schmitz; Sam Gandy; Patrick R Hof; Joseph D Buxbaum; Gregory A Elder
Journal:  Mol Neurodegener       Date:  2009-10-24       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.